ANI Pharmaceuticals Inc (ANIP)
Operating profit margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating income (ttm) | US$ in thousands | 46,971 | 42,065 | 19,122 | -6,193 | -35,283 | -60,826 | -59,393 | -62,033 | -39,793 | -15,739 | -9,375 | -5,129 | -16,016 | -21,018 | -16,492 | 4,107 | 16,351 | 32,467 | 35,253 | 33,224 |
Revenue (ttm) | US$ in thousands | 454,334 | 417,871 | 370,670 | 328,961 | 287,962 | 256,461 | 229,582 | 208,526 | 202,730 | 205,047 | 205,953 | 205,960 | 203,642 | 194,356 | 195,209 | 203,434 | 206,547 | 215,703 | 215,069 | 207,980 |
Operating profit margin | 10.34% | 10.07% | 5.16% | -1.88% | -12.25% | -23.72% | -25.87% | -29.75% | -19.63% | -7.68% | -4.55% | -2.49% | -7.86% | -10.81% | -8.45% | 2.02% | 7.92% | 15.05% | 16.39% | 15.97% |
December 31, 2023 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $46,971K ÷ $454,334K
= 10.34%
ANI Pharmaceuticals Inc's operating profit margin has shown a varying trend over the past eight quarters. The company experienced a positive operating profit margin in the most recent quarters, with percentages of 10.17% in Q4 2023 and 10.20% in Q3 2023. This indicates that the company's ability to generate profits from its core operations has improved.
However, looking back further, there was a significant drop in the operating profit margin in Q2 2023 to 7.34%, indicating a temporary decrease in profitability during that period. The company faced challenges in maintaining its profitability earlier, as seen in Q1 2023 with a low operating profit margin of 1.31%.
Over a year ago, in Q4 2022, ANI Pharmaceuticals Inc suffered from a negative operating profit margin of -8.13%, which continued to decline in Q3 2022 and Q2 2022 with percentages of -18.10% and -21.33% respectively. The company's operating performance was weakest in Q1 2022, with an operating profit margin of -21.63%.
Overall, ANI Pharmaceuticals Inc has seen fluctuations in its operating profit margin, with recent quarters showing signs of improvement. It is important for the company to continue monitoring and managing its operational efficiency and cost structure to sustain and potentially enhance its profitability in the future.
Peer comparison
Dec 31, 2023